To the best of our knowledge, this case represents the first patient with Mitraclip, Amplatzer, and TricValve devices with a profound clinical improvement and long-term follow-up. In addition, this case illustrates how the treatment of high-risk patients with polyvalvular disease has changed in the last few years.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.25270/jic/22.00152 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!